# \[e-drug\] Revision on US and Brazilian ARV Price comparison **URL:** \ **Category:** e-drug\ **Created:** [September 5, 2003, 6:01pm UTC](https://talk.edrugplus.org/t/e-drug-revision-on-us-and-brazilian-arv-price-comparison/17594 "2003-09-05T18:01:59Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![james.love](https://avatars.discourse-cdn.com/v4/letter/j/9fc348/32.png) [@james.love](https://talk.edrugplus.org/u/james.love)\ **Post date:** [September 5, 2003, 6:01pm UTC](https://talk.edrugplus.org/t/e-drug-revision-on-us-and-brazilian-arv-price-comparison/17594/1 "2003-09-05T18:01:59Z")
E-drug: Revision on US and Brazilian ARV Price comparison ------------------------------------------------------------------------- Yesterday we sent out a message to Ip-health and E-drug (cut and pasted below) comparing the prices of ARVs in Brazil and the US and the percentage of the US price that the Brazilian price is. I read the prescribing information for Lopinavir+Ritonavir, so we calculated the daily and then the yearly price assuming half a daily dose. In the table below, this has been corrected. The average price of products invented after 1996 is 23% of the US price, and the average price of products invented before 1996 is 6% of the US price. DRUG/ /USA / Brazil / %USA Prior 1996 inventions off patent in Brazil AZT/ $3,767 / $ 241 / 6% 3TC/ $3,285 / $ 168 / 5% Nevirapine/ $3,891 / $ 204 / 5% ARV Drugs patented in Brazil Nelfinavir/ $6,931 / $1,741 / 25% Efavirenz/ $4,782 / $ 767 / 16% Lopinaivr+Ritonavir / $7,862 / $1,643 / 21% AZT+3TC (Combivir) / $7,023 / $2,190 / 31% ------------------------------------------------- Brazil and US ARV prices compared with affordability analysis In the US, the GDP per person living with HIV is $11,574,242. In Brazil, the GDP per person living with HIV is $741,618, or 6.4 percent of the US income per person living with HIV. One measure of an affordable price for ARV products in Brazil is the ratio of US to Brazil GDP/HIV+. If prices are 6.4 percent of the US price, they are probably affordable if purchased by the State. Prices for ARV products in Brazil depend upon when the products were invented. All ARV products invented before 1996 are generics in Brazil. Products invented after 1996 are on patent. All post 1996 products are much more expensive. The following is a comparison of US and Brazil prices for seven important ARV products. The average price of products invented before 1996 is 6 percent of the US price. The average price of the products invented after 1996 is 29 percent of the US price. If Brazil cannot get the new drugs priced much lower, it will be difficult for Brazil to sustain universal access to HAART treatment. Jamie DRUG/ /USA / Brazil / %USA Prior 1996 inventions off patent in Brazil AZT/ $3,767 / $ 241 / 6% 3TC/ $3,285 / $ 168 / 5% Nevirapine/ $3,891 / $ 204 / 5% ARV Drugs patented in Brazil Nelfinavir/ $6,931 / $1,741 / 25% Efavirenz/ $4,782 / $ 767 / 16% Lopinaivr+Ritonavir / $3,931 / $1,643 / 42% AZT+3TC (Combivir) / $7,023 / $2,190 / 31% -- To send a message to E-Drug, write to: e-drug@healthnet.org To subscribe or unsubscribe, write to: majordomo@healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@healthnet.org Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)